July 18 (Reuters) - Compumedics Ltd CMP.AX :
* FY 2016 guidance update, continuing growth in FY 2017 CMP.AX
* Full-year sales expected to be approximately $37M"
* Compumedics expects similar revenue growth in FY 2017"
* Likely EBITDA ($4.5M-$5.5M) and NPAT ($2.8M-$3.2M) also within guidelines"
* Source text for Eikon ID:nASX2hc7bD
*